Metsera, Inc. presents four studies on GLP-1 receptor agonist MET-097i at the ADA conference, showcasing clinical and preclinical data. Metsera, Inc., a biopharmaceutical company focused on obesity ...
A report prepared for the NASA Applied Science Program and authored by economists at The Brattle Group finds that the use of NASA’s solar and meteorological data services has greatly contributed to ...
Company to host conference call and webcast today at 8:00 A.M. ET NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (MTSR), today announced positive topline data from the Phase 1 clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results